Rifaximin on Intestinally-Related Pathologic Changes in Sickle Cell Disease

Authors

Dibyendu Dutta
Kelvin Li
Barbara Methe
Seah H. Lim, New York Medical CollegeFollow

DOI

10.1002/ajh.25722

Journal Title

American Journal of Hematology

First Page

83

Last Page

86

Document Type

Article

Publication Date

4-2020

Department

Medicine

Keywords

Abdominal Pain, Anemia, Sickle Cell, Anti-Bacterial Agents, Bacterial Translocation, Biomarkers, Dysbiosis, Gastrointestinal Agents, Gastrointestinal Microbiome, Humans, Indican, L-Selectin, Neutrophil Activation, Rifaximin

Disciplines

Medical Pathology | Medicine and Health Sciences | Other Analytical, Diagnostic and Therapeutic Techniques and Equipment | Therapeutics

Recommended Citation

Dutta, D., Li, K., Methe, B., & Lim, S. H. (2020). Rifaximin on Intestinally-Related Pathologic Changes in Sickle Cell Disease. American Journal of Hematology, 95 (4), 83-86. https://doi.org/10.1002/ajh.25722